StockWatch
·
Pharmaceuticals
Board Meeting21 May 2026, 12:52 pm

Brawn Biotech Board Meeting on May 29, 2026

AI Summary

Brawn Biotech Ltd has announced a meeting of its Board of Directors scheduled for May 29, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The trading window, which was closed on March 30, 2026, will remain closed until May 31, 2026, and will reopen on June 1, 2026.

Key Highlights

  • Board meeting scheduled for May 29, 2026 to approve audited financial results.
  • Financial results are for the quarter and year ended March 31, 2026.
  • Trading window remains closed until May 31, 2026, reopening on June 1, 2026.